VivoSeq
Other

Chronic Neck Pain

7

Pipeline Programs

6

Active Trials

4

Companies Involved

Chronic Neck Pain is an early-stage landscape with 7 programs across 4 companies. The most active players are Averitas Pharma, Inc., Kenvue Brands, Menna Allah Ahmed Marei Elnaggar. 2 therapies are approved.

Pipeline Metrics

Competitive Density

36/100

Pipeline Velocity

25/100

Mech. Concentration

33/100

Completion Rate

83/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

14

clinical trials

Completed5 · 36%
Not yet recruiting3 · 21%
Unknown status2 · 14%
Terminated1 · 7%
Enrolling by invitation1 · 7%
Recruiting1 · 7%
Other1 · 7%

Trial Activity

14 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)